What was studied?
Human adipose-derived stromal cells were studied in culture and after pretreatment before use in a mouse kidney-injury model.
What did the researchers report?
MOTS-c activated metabolic signaling but reduced proliferation and increased selected senescence markers. Pretreated cells did not restore the expected repair outcomes.
What are the limits?
This negative, context-dependent finding cautions against equating pathway activation with benefit. Human-derived cells are not the same as a clinical intervention in human patients.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.